ATE445647T1 - Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür - Google Patents

Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür

Info

Publication number
ATE445647T1
ATE445647T1 AT04805265T AT04805265T ATE445647T1 AT E445647 T1 ATE445647 T1 AT E445647T1 AT 04805265 T AT04805265 T AT 04805265T AT 04805265 T AT04805265 T AT 04805265T AT E445647 T1 ATE445647 T1 AT E445647T1
Authority
AT
Austria
Prior art keywords
human
immunoglobulin
transgenic
heavy chain
constant region
Prior art date
Application number
AT04805265T
Other languages
English (en)
Inventor
Michel Cogne
Christophe Sirac
Micael Bardel
Catherine Decourt
Morvan Caroline Le
Original Assignee
Centre Nat Rech Scient
Univ Limoges
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Limoges filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE445647T1 publication Critical patent/ATE445647T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04805265T 2003-10-24 2004-10-21 Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür ATE445647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312502A FR2861255B1 (fr) 2003-10-24 2003-10-24 Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
PCT/FR2004/002701 WO2005047333A1 (fr) 2003-10-24 2004-10-21 Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.

Publications (1)

Publication Number Publication Date
ATE445647T1 true ATE445647T1 (de) 2009-10-15

Family

ID=34400790

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805265T ATE445647T1 (de) 2003-10-24 2004-10-21 Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür

Country Status (8)

Country Link
US (1) US8629317B2 (de)
EP (1) EP1680449B1 (de)
JP (1) JP2008501303A (de)
AT (1) ATE445647T1 (de)
DE (1) DE602004023637D1 (de)
ES (1) ES2335018T3 (de)
FR (1) FR2861255B1 (de)
WO (1) WO2005047333A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926438B1 (fr) * 2008-01-22 2013-01-11 Univ Limoges Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe g et ses applications
LT2346994T (lt) 2008-09-30 2022-03-10 Ablexis, Llc Knock-in pelė, skirta chimerinių antikūnų gamybai
BRPI1005959A2 (pt) * 2009-02-27 2015-08-25 Genentech Inc "vetor de direcionamento, método de produção de uma célula haste embriônica alterada in vitro, animal não humano, mamífero não humano, modelo animal, modelo animal/mamífero não humano, método de teste de terapia de alergia, linhagem celular, célula isolada de um modelo animal, processo de elaboração de um modelo animal não humano e camundongo recombinante
ES2595376T3 (es) * 2009-12-10 2016-12-29 Regeneron Pharmaceuticals, Inc. Ratones que producen anticuerpos de cadena pesada
LT3248462T (lt) 2010-03-31 2024-05-27 Ablexis, Llc Pelių genų inžinerija, skirta chimerinių antikūnų gamybai
KR102434557B1 (ko) 2010-08-02 2022-08-23 리제너론 파아마슈티컬스, 인크. Vl 도메인을 포함하는 결합 단백질을 생성하는 마우스
EP2820947A1 (de) * 2013-07-05 2015-01-07 B Cell Design Transgenes nichtmenschliches Säugetier zur Herstellung chimärer humaner Immunglobulin-E-Antikörper
EP2905031A1 (de) 2014-02-10 2015-08-12 B Cell Design Neues, nicht-HIV-Impfstoff-Antigen aus der vaginalen Mikrobiota zur Induzierung einer mukosalen, neutralisierenden, schützenden Antikörperreaktion gegen eine HIV-Infektion
KR20210088756A (ko) 2014-03-21 2021-07-14 리제너론 파마슈티칼스 인코포레이티드 단일 도메인 결합 단백질을 생산하는 비-인간 동물
US20150266976A1 (en) 2014-03-21 2015-09-24 Regeneron Pharmaceuticals, Inc. Vl antigen binding proteins exhibiting distinct binding characteristics
KR20230155600A (ko) 2014-04-03 2023-11-10 아이쥐엠 바이오사이언스 인코포레이티드 변형된 j-사슬
ES2874558T3 (es) 2015-03-04 2021-11-05 Igm Biosciences Inc Moléculas de unión a CD20 y usos de las mismas
JP2018508224A (ja) 2015-03-19 2018-03-29 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. 抗原を結合する軽鎖可変領域を選択する非ヒト動物
AU2016329197B2 (en) 2015-09-30 2021-01-21 Igm Biosciences, Inc. Binding molecules with modified J-chain
WO2017059387A1 (en) 2015-09-30 2017-04-06 Igm Biosciences, Inc. Binding molecules with modified j-chain
EP3398967A1 (de) 2017-05-04 2018-11-07 B Cell Design Antikörper gegen karzinoembryonisches antigen zur krebstherapie und -diagnose
CN108486126A (zh) * 2018-03-27 2018-09-04 重庆金迈博生物科技有限公司 一种核酸分子及其在人源化抗体中的应用
WO2020053865A1 (en) * 2018-09-13 2020-03-19 Ramot At Tel-Aviv University Ltd. Genetic engneering of b cell receptors and uses thereof in antigen-induced antibody secretion
US20220340926A1 (en) * 2019-05-27 2022-10-27 Transgenic Inc. Exon-humanized mouse
CN115197942A (zh) * 2021-04-09 2022-10-18 北京大学第一医院 一种可表达人源IgA1蛋白的鼠模型及其构建方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
JPH08140528A (ja) * 1993-12-03 1996-06-04 Genpharm Internatl Inc 異種抗体を産生することができるトランスジェニック非ヒト動物
US5714352A (en) * 1996-03-20 1998-02-03 Xenotech Incorporated Directed switch-mediated DNA recombination
US6833268B1 (en) * 1999-06-10 2004-12-21 Abgenix, Inc. Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
JP2005510201A (ja) * 2001-01-26 2005-04-21 アブジェニックス インコーポレイテッド Hiv−1に対する中和ヒトモノクローナル抗体、それらの産生および使用

Also Published As

Publication number Publication date
EP1680449A1 (de) 2006-07-19
DE602004023637D1 (de) 2009-11-26
WO2005047333A1 (fr) 2005-05-26
US20070248601A1 (en) 2007-10-25
FR2861255B1 (fr) 2006-02-17
EP1680449B1 (de) 2009-10-14
ES2335018T3 (es) 2010-03-18
US8629317B2 (en) 2014-01-14
FR2861255A1 (fr) 2005-04-29
JP2008501303A (ja) 2008-01-24

Similar Documents

Publication Publication Date Title
ATE445647T1 (de) Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür
US20230189772A1 (en) Humanized il-15 animals
EP1597382B1 (de) Gen-modifizierte nicht-menschliche säuger und zellen
ES2641920T3 (es) Ingeniería genética de animales no humanos para la producción de anticuerpos quiméricos
CA2376299A1 (en) Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
BR122020013427B1 (pt) Método para fazer um camundongo, uma célula ou tecido derivado de um camundongo e um hibridoma
AU2005213965A1 (en) Gene disruptions, compositions and methods relating thereto
AU2005224992B2 (en) Transgenic model for Alzheimer's disease
MX2021014893A (es) Animales no humanos que tienen un repertorio de cadena ligera lambda limitado expresado a partir del locus kappa y usos de estos.
JP3765574B2 (ja) 逆向き反復配列を含む組み換え遺伝子及びその利用
KR20210020018A (ko) 진행성 골화성 섬유이형성증의 설치류 모델
KR20150126867A (ko) 조건적 Acvr1 돌연변이체 대립형질을 갖는 설치류
DE60118913T2 (de) Transgenes tiermodell für neurodegenerative erkrankungen
JP2004523234A5 (de)
US20060265772A1 (en) Histamine hyperproductive animal
WO2023046201A1 (en) Genetically modified non-human animal with human or chimeric genes
CN114606270A (zh) 一种Mia3条件性基因敲除小鼠模型的构建方法
JP2004049083A (ja) パピローマウイルスベクターを用いたRNAi表現型を有する非ヒト哺乳動物の作製方法
JPWO2021216505A5 (de)
PT1255437E (pt) Feromonas calmantes de aves, para diminuir o stress, anxiedade e agressividade

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties